Psychedelic-assisted therapy for mental health: Policy considerations

February 12, 2025 DOI: 10.58248/pb64 (opens in new tab)

Summary

AI-generated from the abstract

Clinical trials are investigating psychedelic-assisted therapy for mental health conditions, with associated benefits, risks, and policy considerations.

Abstract

Psychedelic-assisted therapy for mental health conditions is being researched in clinical trials. There are associated benefits, risks and policy considerations.

Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment Medical Science Monitor June 30, 2025 4 citations via OpenAlex
Ethics of Psychedelic-Assisted Psychotherapy Cureus January 25, 2026 via OpenAlex
Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations Expert Opinion on Pharmacotherapy March 24, 2026 via OpenAlex
A Promise Without Panacea: Psychedelic-Assisted Therapies in Modern Psychiatry. Cureus January 1, 2026 via PubMed
Psychedelic-Assisted Therapy in Clinical Practice August 30, 2024

Comments

No comments yet.

Summary

Abstract

Related reading

Comments